COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02569320
Brief Title: HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma

First Submitted : October 3, 2015
First Submitted that Met QC Criteria : October 3, 2015
First Posted : October 6, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 13, 2019
Last Update Posted : November 15, 2019